Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.

Gernot Wassmer1

  • 1Institute for Medical Statistics, Informatics, and Epidemiology, University of Cologne, Cologne, Germany. Gernot.Wassmer@medizin.uni-koeln.de

Journal of Biopharmaceutical Statistics
|October 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Note on "A Comparison of Two Methods for Adaptive Multi-Arm Two-Stage Design".

Statistics in medicine·2026
Same author

Clinical trials with interim analyses: standardizing terminology to increase clarity.

Trials·2025
Same author

Two-stage group-sequential designs with delayed responses - what is the point of applying corresponding methods?

BMC medical research methodology·2024
Same author

Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.

Statistics in biopharmaceutical research·2021
Same author

Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptations.

Pharmaceutical statistics·2019
Same author

Recent advances in methodology for clinical trials in small populations: the InSPiRe project.

Orphanet journal of rare diseases·2018
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Adaptive group sequential designs allow data-driven trial modifications without increasing Type I error rates. This study proposes methods for superiority and noninferiority proportion studies using the inverse normal method.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Methods

Background:

  • Multistage adaptive group sequential tests offer flexibility in clinical trials.
  • Maintaining Type I error rate during design modifications is crucial.
  • Conditional error functions and power arguments are key for adaptive trial modifications.

Purpose of the Study:

  • To propose approximate techniques for applying the inverse normal combination testing principle in adaptive superiority and noninferiority proportion studies.
  • To discuss planning and adaptive analysis strategies concerning Type I error, sample size, and power.
  • To demonstrate the calculation of confidence intervals and overall p-values within adaptive designs.

Main Methods:

  • Utilizing multistage adaptive group sequential test designs.

Related Experiment Videos

  • Employing the inverse normal method for combining p-values across trial stages.
  • Developing approximate techniques for proportion studies.
  • Main Results:

    • Demonstrated methods for data-driven design changes without Type I error inflation.
    • Provided strategies for sample size reassessment based on conditional power.
    • Outlined calculations for confidence intervals and overall p-values in adaptive trials.

    Conclusions:

    • Adaptive group sequential designs, particularly using the inverse normal method, provide a robust framework for flexible clinical trial conduct.
    • The proposed techniques facilitate efficient and statistically sound modifications in superiority and noninferiority proportion studies.
    • This approach enhances the ability to adapt trials based on accumulating data while preserving statistical integrity.